164 related articles for article (PubMed ID: 25632915)
1. Time trends of the impact of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs on peptic ulcer bleeding in Japanese patients.
Nagasue T; Nakamura S; Kochi S; Kurahara K; Yaita H; Kawasaki K; Fuchigami T
Digestion; 2015; 91(1):37-41. PubMed ID: 25632915
[TBL] [Abstract][Full Text] [Related]
2. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
3. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
[TBL] [Abstract][Full Text] [Related]
4. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.
Kuyvenhoven JP; Veenendaal RA; Vandenbroucke JP
Scand J Gastroenterol; 1999 Nov; 34(11):1082-6. PubMed ID: 10582757
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
6. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.
Chung WC; Jeon EJ; Kim DB; Sung HJ; Kim YJ; Lim ES; Kim MA; Oh JH
World J Gastroenterol; 2015 Jul; 21(28):8636-43. PubMed ID: 26229405
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding.
Wu CY; Poon SK; Chen GH; Chang CS; Yeh HZ
Scand J Gastroenterol; 1999 Mar; 34(3):234-7. PubMed ID: 10232865
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
[TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
11. Changes of gastric ulcer bleeding in the metropolitan area of Japan.
Kubosawa Y; Mori H; Kinoshita S; Nakazato Y; Fujimoto A; Kikuchi M; Nishizawa T; Suzuki M; Suzuki H
World J Gastroenterol; 2019 Nov; 25(42):6342-6353. PubMed ID: 31754294
[TBL] [Abstract][Full Text] [Related]
12. The influence of etiologic factors on clinical outcome in patients with peptic ulcer bleeding.
Ljubičić N; Puljiz Z; Budimir I; Bišćanin A; Bratanić A; Pavić T; Nikolić M; Hrabar D; Supanc V
Dig Dis Sci; 2012 Dec; 57(12):3195-204. PubMed ID: 22736015
[TBL] [Abstract][Full Text] [Related]
13. Peptic ulcer bleeding: is Helicobacter pylori a risk factor in an endemic area?
Sotoudehmanesh R; Asgari AA; Fakheri HT; Nouraie M; Khatibian M; Shirazian N
Indian J Gastroenterol; 2005; 24(2):59-61. PubMed ID: 15879651
[TBL] [Abstract][Full Text] [Related]
14. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
Chan FK; Ching JY; Suen BY; Tse YK; Wu JC; Sung JJ
Gastroenterology; 2013 Mar; 144(3):528-35. PubMed ID: 23333655
[TBL] [Abstract][Full Text] [Related]
15. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori.
Chason RD; Reisch JS; Rockey DC
Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535
[TBL] [Abstract][Full Text] [Related]
16. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
17. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
Hawkey CJ
Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
[TBL] [Abstract][Full Text] [Related]
18. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of peptic ulcer perforation in Korea.
Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
Mahachai V; Thomson AB; Vilaichone RK
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
